HEALTHSOUTH CORP
10-Q/A, 1997-09-25
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: HEALTHSOUTH CORP, 8-K/A, 1997-09-25
Next: HEALTHSOUTH CORP, S-4, 1997-09-25



   
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A

                                 AMENDMENT NO. 2
    

(Mark One)

[X]    Quarterly  report  pursuant  to  Section  13 or 15(d)  of the  Securities
       Exchange Act of 1934 for the quarterly period ended March 31, 1997; or

[ ]    Transition  report  pursuant  to  Section  13 or 15(d) of the  Securities
       Exchange  Act of 1934 for the  transition  period  from  ____________  to
       _____________.

Commission File Number 1-10315
                       -------

                            HEALTHSOUTH CORPORATION
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)


        Delaware                                                 63-0860407
 ------------------------------                              -------------------
(State or Other Jurisdiction of                              (I.R.S. Employer
 Incorporation or Organization)                              Identification No.)


               ONE HEALTHSOUTH PARKWAY, BIRMINGHAM, ALABAMA 35243
               --------------------------------------------------
                    (Address of Principal Executive Offices)
                                   (Zip Code)

                                 (205) 967-7116
                                 --------------
              (Registrant's Telephone Number, Including Area Code)

         Indicate by check mark whether the Registrant (1) has filed all Reports
required to be filed by Section 13 or 15(d) of the  Securities  and Exchange Act
of 1934  during the  preceding  12 months (or for such  shorter  period that the
Registrant was required to file such Reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                                    YES X    NO
                                       ----    ----

         Indicate  the  number of  shares  outstanding  of each of the  issuer's
classes of common stock, as of the latest practicable date.

              Class                         Outstanding at May 9, 1997
- - --------------------------------            ----------------------------
     COMMON STOCK, PAR VALUE                    343,016,747 SHARES
         $.01 PER SHARE

                                     Page 1
<PAGE>



                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                          QUARTERLY REPORT ON FORM 10-Q

                                      INDEX

PART 1 -- FINANCIAL INFORMATION

                                                                           Page
                                                                           ----
Item 1.  Financial Statements

         Consolidated Balance Sheets (Unaudited) -- March 31, 1997
         and December 31, 1996                                                 3

         Consolidated Statements of Income (Unaudited) -- Three Months
         Ended March 31, 1997 and 1996                                         5

         Consolidated Statements of Cash Flows (Unaudited) -- Three Months
         Ended March 31, 1997 and 1996                                         6

         Notes to Consolidated Financial Statements (Unaudited) -- Three
         Months Ended March 31, 1997 and 1996                                  8

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations                                  11

PART II -- OTHER INFORMATION

Item 2.  Changes in Securities                                                15

Item 4.  Submission of Matters to a Vote of Security Holders                  15

Item 6.  Exhibits and Reports on Form 8-K                                     15

                                     Page 2
<PAGE>



PART I -- FINANCIAL INFORMATION

ITEM 1.           FINANCIAL STATEMENTS

                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS
                           (UNAUDITED - IN THOUSANDS)


<TABLE>
<CAPTION>

                                                                    MARCH 31,                  DECEMBER 31,
                                                                      1997                         1996
                                                              ---------------               ---------------

ASSETS

CURRENT ASSETS
<S>                                                        <C>                           <C>              
     Cash and cash equivalents                              $        151,351              $         150,071
     Other marketable securities                                       3,842                          3,760
     Accounts receivable                                             580,218                        540,389
     Inventories, prepaid expenses, and
       other current assets                                          189,126                        175,582
     Deferred income taxes                                            16,335                         15,238
                                                             ---------------               ----------------
                                TOTAL CURRENT ASSETS                 940,872                        885,040

OTHER ASSETS                                                          99,880                         85,412

PROPERTY, PLANT AND EQUIPMENT--NET                                 1,534,388                      1,464,833

INTANGIBLE ASSETS--NET                                             1,130,699                      1,094,421
                                                             ---------------
                                                                                           ----------------

                                     TOTAL ASSETS           $      3,705,839              $       3,529,706
                                                              ===============              ================
</TABLE>

                                     Page 3

<PAGE>



                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                     CONSOLIDATED BALANCE SHEETS (CONTINUED)
                           (UNAUDITED - IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                                MARCH 31,                  DECEMBER 31,
                                                                                  1997                         1996
                                                                             ---------------               ---------------



LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
<S>                                                                       <C>                           <C>            
      Accounts payable                                                     $        111,869              $       116,451
      Salaries and wages payable                                                     41,712                       67,793
      Accrued interest payable and other liabilities                                118,595                       99,118
      Current portion of long-term debt                                              39,510                       38,726
                                                                             ---------------               ---------------
                            TOTAL CURRENT LIABILITIES                               311,686                      322,088
                                                      
LONG-TERM DEBT                                                                    1,624,311                    1,521,417

DEFERRED INCOME TAXES                                                                42,126                       41,850

OTHER LONG-TERM LIABILITIES                                                           3,335                        3,558

DEFERRED REVENUE                                                                        379                          406

MINORITY INTERESTS-LIMITED PARTNERSHIPS                                              76,935                       71,286

STOCKHOLDERS' EQUITY:
      Preferred Stock, $.10 par value--1,500,000                             
        shares authorized; issued and outstanding--                          
        none                                                                              0                            0
      Common Stock, $.01 par value--500,000,000                              
        shares authorized; 327,384,000 and 326,492,000                       
        shares issued at March 31, 1997 and                                  
        December 31, 1996, respectively                                               3,274                        3,265
      Additional paid-in capital                                                  1,072,718                    1,060,012
      Retained earnings                                                             589,065                      525,718
      Treasury stock                                                                   (323)                        (323)
      Receivable from Employee Stock Ownership Plan                                 (12,247)                     (14,148)
      Notes receivable from stockholders                                             (5,420)                      (5,423)
                                                                             ---------------               ---------------

                                      TOTAL STOCKHOLDERS' EQUITY                  1,647,067                    1,569,101
                                                                                                           ---------------
                                                                             ---------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                 $      3,705,839              $     3,529,706
                                                                             ===============               ===============
</TABLE>

See accompanying notes.


                                     Page 4


<PAGE>




                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME
              (UNAUDITED - IN THOUSANDS, EXCEPT FOR PER SHARE DATA)

<TABLE>
<CAPTION>

                                                                                          THREE MONTHS ENDED
                                                                                              MARCH 31,
                                                                         -----------------------------------------------------
                                                                                1997                             1996
                                                                         --------------------             --------------------

<S>                                                                    <C>                              <C>                  
   
Revenues                                                               $             691,631            $             612,149
Operating units expenses                                                             438,289                          404,801
Corporate general and administrative expenses                                         17,849                           18,449
Provision for doubtful accounts                                                       14,713                           14,102
Depreciation and amortization                                                         57,371                           47,164
Merger costs                                                                          15,875                           28,939
Interest expense                                                                      25,673                           24,851
Interest income                                                                       (1,038)                          (1,827)
                                                                         --------------------             --------------------
                                                                                     568,732                          536,479
                                                                         --------------------             --------------------
    Income before income taxes and
     minority interests                                                              122,899                           75,670
Provision for income taxes                                                            42,411                           24,472
                                                                         --------------------             --------------------
    Income before minority interests                                                  80,488                           51,198
Minority interests                                                                   (15,908)                         (11,517)
                                                                         --------------------             --------------------
    
    Net income                                                         $              64,580            $              39,681
                                                                         ====================             ====================


Weighted average common and common
    equivalent shares outstanding                                                    342,772                          336,151
                                                                         ====================             ====================

Net income per common and common
    equivalent share                                                   $                0.19         $                   0.12
                                                                         ====================             ====================

Net income per common share --
    assuming full dilution                                             $                0.18         $                   0.12
                                                                         ====================             ====================

</TABLE>

See accompanying notes.


                                     Page 5

<PAGE>



                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                           (UNAUDITED - IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                                          THREE MONTHS ENDED
                                                                                               MARCH 31,
                                                                           -----------------------------------------------
                                                                                     1997                         1996
                                                                           -------------------            ----------------

OPERATING ACTIVITIES
<S>                                                                        <C>                        <C>               
           Net income                                                      $          64,580          $           39,681
           Adjustments to reconcile net income to net
             cash provided by operating activities:
               Depreciation and amortization                                          57,371                      47,164
               Provision for doubtful accounts                                        14,713                      14,102
               Income applicable to minority interests of
                  limited partnerships                                                15,908                      11,517
               Merger costs                                                           15,875                      28,939
               Provision for deferred income taxes                                     3,525                         392
               Provision for deferred revenue                                            (27)                       (317)
               Changes in operating assets and liabilities, net of
                 effects of acquisitions:
                 Accounts receivable                                                 (47,624)                    (65,655)
                 Inventories, prepaid expenses and other current
                    assets                                                           (14,372)                     10,257
                 Accounts payable and accrued expenses                               (34,425)                    (22,965)
                                                                          -------------------           ----------------

                                                     NET CASH PROVIDED BY
                                                     OPERATING ACTIVITIES             75,524                      63,115
INVESTING ACTIVITIES
           Purchases of property, plant and equipment                                (96,447)                    (53,329)
           Additions to intangible assets, net of effects of
             acquisitions                                                            (40,866)                    (39,060)
           Assets obtained through acquisitions, net of liabilities
             assumed                                                                 (28,964)                    (26,892)
           Changes in other assets                                                   (14,468)                     (2,387)
           Proceeds received on sale of other marketable
             securities                                                                   30                          35
           Investments in other marketable securities                                   (112)                          0
                                                                          -------------------           ----------------

                                    NET CASH USED IN INVESTING ACTIVITIES           (180,827)                   (121,633)

</TABLE>

                                     Page 6
<PAGE>



                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
                           (UNAUDITED - IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                                          THREE MONTHS ENDED
                                                                                               MARCH 31,
                                                                           -----------------------------------------------
                                                                                     1997                         1996
                                                                           -------------------            ----------------
FINANCING ACTIVITIES
<S>                                                                            <C>                         <C>    
 Proceeds from borrowings                                                            193,900                     142,822
 Principal payments on long-term debt and leases                                     (90,445)                   (123,835)
 Proceeds from exercise of options                                                    11,483                      12,898
 Purchase of treasury stock                                                                0                        (500)
 Reduction in receivable from Employee Stock
    Ownership Plan                                                                     1,901                       1,738
 Decrease in loans to stockholders                                                         3                          44
 Dividends paid                                                                            0                        (286)
 Proceeds from investment by minority interests                                        3,009                       1,680
 Payment of cash distributions to limited partners                                   (13,268)                    (10,617)
                                                                           -------------------             ----------------

                                                  NET CASH PROVIDED FROM
                                                     FINANCING ACTIVITIES            106,583                      23,944
                                                                           -------------------             ----------------

                                          INCREASE (DECREASE) IN CASH AND
                                                         CASH EQUIVALENTS              1,280                     (34,574)

 Cash and cash equivalents at beginning of period                                    150,071                     151,812
                                                                           -------------------             ----------------

                                                CASH AND CASH EQUIVALENTS
                                                         AT END OF PERIOD  $         151,351               $     117,238
                                                                           ===================             ================

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
 Cash paid during the year for:
     Interest                                                              $          18,423               $      16,473
     Income taxes                                                                     34,635                      20,069

</TABLE>

See accompanying notes.

                                     Page 7


<PAGE>

                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                   THREE MONTHS ENDED MARCH 31, 1997 AND 1996

NOTE  1  --    The accompanying  consolidated  financial  statements include the
               accounts  of  HEALTHSOUTH  Corporation  (the  "Company")  and its
               subsidiaries. This information should be read in conjunction with
               the  Company's  Annual  Report on Form 10-K for the  fiscal  year
               ended  December 31,  1996.  It is  management's  opinion that the
               accompanying   consolidated   financial  statements  reflect  all
               adjustments  (which are normal recurring  adjustments,  except as
               otherwise  indicated)  necessary for a fair  presentation  of the
               results  for  the  interim  period  and  the  comparable   period
               presented.

NOTE  2  --    During 1995,  the Company  entered into a Credit  Agreement  with
               NationsBank,  N.A.  ("NationsBank") and other participating banks
               (the "1995 Credit Agreement") which consisted of a $1,000,000,000
               revolving credit facility. On April 18, 1996, the Company amended
               and  restated  the 1995 Credit  Agreement to increase the size of
               the revolving credit facility to $1,250,000,000 (the "1996 Credit
               Agreement"). Interest is paid based on LIBOR plus a predetermined
               margin,  a  base  rate,  or  competitively  bid  rates  from  the
               participating  banks. The Company is required to pay a fee on the
               unused  portion of the  revolving  credit  facility  ranging from
               0.08%  to  0.25%,   depending  on  certain  defined  ratios.  The
               principal  amount  is  payable  in full on March  31,  2001.  The
               Company  provided a negative  pledge on all assets under the 1996
               Credit  Agreement,  and the lenders  released the first  priority
               security  interest  in all  shares  of  stock  of  the  Company's
               subsidiaries and rights and interests in the Company's controlled
               partnerships  which  had  been  granted  under  the  1995  Credit
               Agreement.   In  connection  with  the  pending   acquisition  of
               Horizon/CMS   (see  Note  4),   the   Company   has   obtained  a
               fully-underwritten   commitment  from  NationsBank,  N.A.  for  a
               $1,000,000,000  Senior Bridge Loan Facility on substantially  the
               same  terms  as  the  1996   Credit   Agreement.   In   addition,
               NationsBank,  N.A. has  provided the Company with a  $300,000,000
               interim revolving credit facility for working capital purposes on
               substantially  the  same  terms  as the  1996  Credit  Agreement,
               pending the closing of the Senior Bridge Loan Facility.

               On March 24,  1994,  the Company  issued  $250,000,000  principal
               amount of 9.5% Senior  Subordinated Notes due 2001 (the "Notes").
               Interest  is  payable  on April 1 and  October  1. The  Notes are
               senior subordinated  obligations of the Company and, as such, are
               subordinated  to all existing and future senior  indebtedness  of
               the  Company.   Also  on  March  24,  1994,  the  Company  issued
               $100,000,000  principal  amount  of 5%  Convertible  Subordinated
               Debentures due 2001 (the "Convertible Debentures"). An additional
               $15,000,000 principal amount of Convertible Debentures was issued
               in April 1994 to cover underwriters' overallotments.  Interest is
               payable on April 1 and October 1. The Convertible  Debentures are
               convertible into Common Stock of the Company at the option of the
               holder at a  conversion  price of $9.406  per  share,  subject to
               adjustment in certain events.  The net proceeds from the issuance
               of the Notes and Convertible  Debentures were used by the Company
               to pay down  indebtedness  outstanding  under its other  existing
               credit facilities.

                                     Page 8
<PAGE>




                 At March  31,  1997  and  December  31,  1996,  long-term  debt
consisted of the following:

<TABLE>
<CAPTION>

                                                             March 31,            December 31,
                                                                1997                  1996
                                                          -----------------     -----------------
                                                                      (in thousands)
<S>                                                      <C>                     <C>     
       Advances under the $1,250,000,000 1996
            Credit Agreement                                    $1,164,000              $995,000
       9.5% Senior Subordinated Notes due 2001                     250,000               250,000
       5% Convertible Subordinated Debentures due 2001             115,000               115,000
       Other long-term debt                                        134,821               200,143
                                                          -----------------     -----------------
                                                                 1,663,821             1,560,143
       Less amounts due within one year                             39,510                38,726
                                                          -----------------     -----------------
                                                                $1,624,311            $1,521,417
                                                          =================     =================
</TABLE>


               Subsequent  to March 31,  1997,  the  holders of the  Convertible
               Debentures  surrendered  substantially  all  of  the  Convertible
               Debentures for conversion into approximately 12,226,000 shares of
               the Company's Common Stock.

NOTE  3  --    On March 3, 1997,  the Company  consummated  the  acquisition  of
               Health Images, Inc. ("Health Images") in a transaction  accounted
               for  as  a  pooling  of  interests.  Accordingly,  the  Company's
               historical  financial  statements  for all  periods  prior to the
               effective  date of the merger  have been  restated to include the
               results  of Health  Images.  In the  transaction,  Health  Images
               stockholders  received  approximately  10,343,000  shares  of the
               Company's  Common Stock.  Health Images  operates 49 freestanding
               diagnostic centers in 13 states and six in the United Kingdom.

               Costs  and  expenses  of  $15,875,000,   primarily   representing
               accounting,  legal and financial advisory  services,  incurred by
               the Company in  connection  with the merger have been recorded in
               operations  during the quarter ending March 31, 1997 and reported
               as Merger Costs in the  accompanying  consolidated  statements of
               income. The effects of conforming the accounting  policies of the
               Company and Health Images were not material.

   
Combined  and  separate  results of the Company and Health  Images for the three
months ended March 31, 1997 and 1996 are as follows (in thousands):

                                                         HEALTH
                                        HEALTHSOUTH      IMAGES         COMBINED
                                        -----------    -----------    ----------
Three Months ended March 31, 1997
 Revenues                               $  658,898     $   32,733     $  691,631
 Net Income                                 63,433          1,147         64,580

Three Months ended March 31, 1996
 Revenues                               $  581,234     $   30,915     $  612,149
 Net Income                                 37,851          1,830         39,681
    

               During  1996,  the  Company   consummated   the   acquisition  of
               ReadiCare, Inc. ("ReadiCare") in a transaction accounted for as a
               pooling of interests.  Prior to the merger, ReadiCare reported on
               a fiscal year ending on February 28. Accordingly,  at the time of
               the merger, the historical financial statements of ReadiCare were
               recast to a November 30 fiscal year end to more  closely  conform
               to the Company's  calendar fiscal year end.  Beginning January 1,
               1997, all facilities  acquired in the ReadiCare  merger adopted a
               December 31 fiscal year end;  therefore,  ReadiCare's  historical
               results of operations  for the one month ended December 31, 1996,
               which included revenues of $3,266,000 and a net loss of $926,000,
               are not  included in the  Company's  consolidated  statements  of
               income.  ReadiCare's  cash  flow for the one month  period  ended
               December 31, 1996 of ($543,000)  is included in the  accompanying
               statement  of cash  flows for the three  months  ended  March 31,
               1997.

NOTE  4  --    During the first three  months of 1997,  the Company  acquired 32
               outpatient  rehabilitation  facilities,  two  outpatient  surgery
               centers and one  diagnostic  imaging  center.  The total purchase
               price of the acquired  facilities was approximately  $28,964,000.
               The Company  also entered into  non-compete  agreements  totaling
               approximately  $3,675,000 in connection with these  transactions.
               The cost in excess of the acquired facilities' net asset

                                     Page 9

<PAGE>



               value was  approximately  $21,602,000.  The results of operations
               (not  material   individually  or  in  the  aggregate)  of  these
               acquisitions   are   included  in  the   consolidated   financial
               statements from their respective acquisition dates.

               On February  17,  1997,  the Company  entered  into a  definitive
               agreement   to   acquire   Horizon/CMS   Healthcare   Corporation
               ("Horizon/CMS")   in  a  stock-for-stock   merger  in  which  the
               stockholders  of Horizon/CMS  will receive  0.84338 of a share of
               the Company's common stock per share of Horizon/CMS common stock.
               The  transaction  is  valued  at  approximately   $1,600,000,000,
               including  the   assumption  by  the  Company  of   approximately
               $700,000,000  in  Horizon/CMS  debt.  It  is  expected  that  the
               acquisition will be accounted for as a purchase.  Consummation of
               the  transaction  is  subject to  various  regulatory  approvals,
               including   clearance  under  the   Hart-Scott-Rodino   Antitrust
               Improvements  Act,  and  to the  satisfaction  of  certain  other
               conditions.   The   Company   currently   anticipates   that  the
               transaction will be consummated in mid-1997.
   
NOTE  5  --    During  the first  three  months  of 1997,  the  Company  granted
               incentive and nonqualified stock options to certain Directors and
               employees for 2,240,000 shares of Common Stock at exercise prices
               ranging from $18.44 to $20.81 per share.
    
NOTE  6  --    On January 18, 1997, the Company's Board of Directors  authorized
               a  two-for-one  stock  split to be effected in the form of a 100%
               stock  dividend,   subject  to  the  approval  by  the  Company's
               stockholders of an amendment to its Certificate of  Incorporation
               increasing  the number of authorized  shares of common stock from
               250,000,000 to 500,000,000.  The Company's  stockholders approved
               the amendment on March 12, 1997.  The stock  dividend was payable
               on March  17,  1997 to  holders  of  record  on March  13,  1997.
               Accordingly,  all  share and per share  amounts  included  in the
               accompanying  financial  statements  have been  restated  to give
               effect to the stock split.

NOTE  7  --    In February 1997, the Financial Accounting Standards Board issued
               Statement No. 128, "Earnings per Share",  which is required to be
               adopted on December 31, 1997.  At that time,  the Company will be
               required to change the method  currently used to compute earnings
               per  share  and to  restate  all  prior  periods.  Under  the new
               requirements  for  calculating  primary  earnings per share,  the
               dilutive effect of stock options will be excluded.  The impact is
               expected to result in an increase in primary  earnings  per share
               for the quarters ended March 31, 1997 and March 31, 1996 of $0.01
               and $0.01 per share,  respectively.  The impact of Statement  No.
               128 on the  calculation  of fully diluted  earnings per share for
               these quarters is not expected to be material.

                                    Page 10
<PAGE>




ITEM 2.           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS


GENERAL

         The Company provides outpatient and rehabilitative  healthcare services
through its inpatient and outpatient rehabilitation facilities, surgery centers,
diagnostic centers and medical centers.  The Company has expanded its operations
through the acquisition or opening of new facilities and satellite locations and
by enhancing its existing operations. As of March 31, 1997, the Company had over
1,200  locations in 50 states,  the District of Columbia and the United Kingdom,
including  approximately 780 outpatient  rehabilitation  locations, 97 inpatient
rehabilitation  facilities,  four  medical  centers,  140  surgery  centers,  73
diagnostic centers and approximately 116 locations  providing other patient care
services.

         The Company's  revenues  include net patient service revenues and other
operating  revenues.  Net patient service revenues are reported at estimated net
realizable  amounts  from  patients,  insurance  companies,  third-party  payors
(primarily  Medicare and  Medicaid) and others for services  rendered.  Revenues
from third-party  payors also include  estimated  retroactive  adjustments under
reimbursement  agreements  which are subject to final review and  settlement  by
appropriate authorities.  Management determines allowances for doubtful accounts
and  contractual  adjustments  based on historical  experience  and the terms of
payor contracts. Net accounts receivable include only those amounts estimated by
management to be collectible.

         The Company determines the amortization period of the cost in excess of
net asset value of purchased  facilities based on an evaluation of the facts and
circumstances of each individual purchase  transaction.  The evaluation includes
an analysis of historic and projected  financial  performance,  an evaluation of
the  estimated  useful life of the  buildings  and fixed  assets  acquired,  the
indefinite  useful  life of  Certificates  of Need and  licenses  acquired,  the
competition  within local markets,  lease terms where applicable,  and the legal
terms  of  partnerships  where  applicable.  The  Company  utilizes  independent
appraisers and relies on its own management  expertise in evaluating each of the
factors  noted above.  With respect to the carrying  value of the excess of cost
over net asset value of purchased  facilities and other intangible  assets,  the
Company determines on a quarterly basis whether an impairment event has occurred
by  considering  factors  such as the market value of the asset,  a  significant
adverse change in legal factors or in the business climate,  adverse action by a
regulator, a history of operating losses or cash flow losses, or a projection of
continuing  losses  associated with an operating  entity.  The carrying value of
excess cost over net asset value of purchased  facilities  and other  intangible
assets will be evaluated if the facts and circumstances suggest that it has been
impaired.  If this evaluation  indicates that the value of the asset will not be
recoverable,  as determined based on the  undiscounted  cash flows of the entity
acquired over the remaining amortization period, the Company's carrying value of
the asset will be reduced by the estimated shortfall of cash flows.

         The  Company,  in many  cases,  operates  more  than one site  within a
market. In such markets,  there is customarily an outpatient center or inpatient
facility with associated  satellite  outpatient  locations.  For purposes of the
following  discussion  and  analysis,  same store  operations  are  measured  on
locations within markets in which similar  operations  existed at the end of the
period and include the operations of additional locations opened within the same
market. New store operations are measured on locations within new markets.

         Effective  March 3, 1997, the Company  consummated  the  acquisition of
Health  Images,  Inc.  ("Health  Images")  through a merger  accounted  for as a
pooling of interests.  Accordingly, the Company's financial statements have been
restated to include the results of Health Images for all periods  presented (see
Note 3 of "Notes to Consolidated  Financial Statements" for further discussion).
All data set forth for

                                    Page 11
<PAGE>



periods  prior to December 31, 1996  relating to revenues  derived from Medicare
and Medicaid do not take into account revenues of the Health Images facilities.


RESULTS OF OPERATIONS -- THREE MONTHS ENDED MARCH 31, 1997

         The  Company  operated  approximately  780  outpatient   rehabilitation
locations  (which  includes base  facilities and  satellites) at March 31, 1997,
compared  to 624  outpatient  rehabilitation  locations  at March 31,  1996.  In
addition,  the Company  operated 97 inpatient  rehabilitation  facilities,  four
medical  centers,  140 surgery centers,  and 73 diagnostic  centers at March 31,
1997, compared with 95 inpatient  facilities,  five medical centers, 128 surgery
centers and 72 diagnostic centers at March 31, 1996.

         The Company's  operations  generated  revenues of $691,631,000  for the
quarter ended March 31, 1997, an increase of $79,482,000,  or 13.0%, as compared
to the same period in 1996.  The increase in revenues is primarily  attributable
to increases in patient  volume and the addition of new  outpatient  and surgery
centers.  Same  store  revenues  for the  quarter  ended  March  31,  1997  were
$670,119,000,  an  increase  of  $57,970,000,  or 9.5%,  as compared to the same
period in 1996. New store  revenues were  $21,512,000.  Revenues  generated from
patients under Medicare and Medicaid plans respectively  accounted for 37.6% and
2.7% of revenue  for the first  quarter of 1997,  compared to 38.3% and 2.9% for
the same period in 1996.  Revenues from any other single  third-party payor were
not significant in relation to the Company's revenues.  During the first quarter
of 1997,  same store  outpatient  visits,  inpatient  days,  surgical  cases and
diagnostic cases increased 16.4%, 10.3%, 6.5% and 11.4%,  respectively.  Revenue
per outpatient visit,  inpatient day, surgical case and diagnostic case for same
store operations increased by 0.4%, 0.1%, 3.7% and 5.1%, respectively.

   
         Operating expenses, at the operating unit level, were $438,289,000,  or
63.4% of revenues,  for the quarter ended March 31, 1997,  compared to $404,801,
or 66.1% of revenues,  for the first quarter of 1996.  The decrease in operating
expenses  as a  percentage  of revenues is  primarily  attributable  to the 9.5%
increase  in same store  revenues noted  above.  In same store  operations,  the
incremental costs associated with increased revenues are significantly less as a
percentage  of those  increased  revenues.  Same store  operating  expenses were
$424,664,000,  or 63.4% of comparable revenue. New store operating expenses were
$13,625,000,   or  63.3%  of   comparable   revenue.   Corporate   general   and
administrative  expenses  decreased from $18,449,000  during the 1996 quarter to
$17,849,000  during the 1997  quarter.  As a  percentage  of revenue,  corporate
general and  administrative  expenses decreased from 3.0% in the 1996 quarter to
2.6% in the 1997 quarter.  The provision for doubtful  accounts was $14,713,000,
or 2.1% of revenues, for the first quarter of 1997, compared to $14,102,000,  or
2.3% of revenues,  for the same period in 1996.  Management  believes  that this
provision is adequate to cover any uncollectible revenues.    

         Depreciation and  amortization  expense was $57,371,000 for the quarter
ended March 31, 1997,  compared to $47,164,000  for the same period in 1996. The
increase represents the investment in additional assets by the Company. Interest
expense was  $25,673,000  for the  quarter  ended  March 31,  1997,  compared to
$24,851,000 for the quarter ended March 31, 1996. For the first quarter of 1997,
interest income was $1,038,000,  compared to $1,827,000 for the first quarter of
1996.

         As a result of the Health Images  acquisition,  the Company  recognized
$15,875,000,  primarily  representing  accounting,  legal and financial advisory
services, in merger costs during the first three months of 1997.

         Income before minority interests and income taxes for the first quarter
of 1997 was  $122,899,000,  compared to $75,670,000 for the same period in 1996.
Minority  interests  decreased income before income taxes by $15,908,000 for the
quarter ended March 31, 1997,  compared to decreasing income before income taxes
by $11,517,000 for the first quarter of 1996. The provision for income taxes for
the first quarter of 1997 was $42,411,000,  compared to $24,472,000 for the same
period  in  1996,   resulting  in  effective  tax  rates  of  39.6%  and  38.1%,
respectively. Net income for the first quarter of 1997 was $64,580,000, compared
to $39,681,000 for the first quarter of 1996.

                                    Page 12

<PAGE>



LIQUIDITY AND CAPITAL RESOURCES

         As of March 31, 1997, the Company had working capital of  $629,186,000,
including cash and marketable  securities of  $155,193,000.  Working  capital at
December 31, 1996 was $562,952,000,  including cash and marketable securities of
$153,831,000.  For the first three months of 1997,  cash  provided by operations
was $75,524,000,  compared to $63,115,000 for the same period in 1996. Additions
to property, plant, and equipment and acquisitions accounted for $96,447,000 and
$28,964,000,  respectively,  during the first three  months of 1997.  Those same
investing activities accounted for $53,329,000 and $26,892,000, respectively, in
the  same  period  in  1996.  Financing  activities  provided  $106,583,000  and
$23,944,000  during the first three months of 1997 and 1996,  respectively.  Net
borrowing  proceeds  (borrowing  less principal  reductions) for the first three
months of 1997 and 1996 were $103,455,000 and $18,987,000, respectively.

         Accounts  receivable were  $580,218,000 at March 31, 1997,  compared to
$540,389,000  at  December  31,  1996.  The number of days of average  quarterly
revenues in ending receivables at March 31, 1997 was 75.5, compared to 76.8 days
of average  annual  revenues in ending  receivables  at December 31,  1996.  The
concentration  of net accounts  receivable  from patients,  third-party  payors,
insurance  companies and others at March 31, 1997 is consistent with the related
concentration of revenues for the period then ended.

         At March 31, 1997, the Company had a  $1,250,000,000  revolving line of
credit with NationsBank,  N.A.  (Carolinas) and other  participating  banks (the
"1996 Credit  Agreement").  Interest is paid based on LIBOR plus a predetermined
margin, a base rate or  competitively  bid rates from the  participating  banks.
This credit facility has a maturity date of March 31, 2001. The Company provided
a negative  pledge on all assets for the 1996 Credit  Agreement.  The  effective
interest rate on the average  outstanding  balance  under the revolving  line of
credit was 5.78% for the three  months  ended  March 31,  1997,  compared to the
average  prime rate of 8.27%  during the same  period.  At March 31,  1997,  the
Company had drawn $1,164,000,000 under the 1996 Credit Agreement.

         On February 17, 1997, the Company  entered into a definitive  agreement
to   acquire   Horizon/CMS   Healthcare   Corporation   ("Horizon/CMS")   in   a
stock-for-stock  merger in which the  stockholders  of Horizon/CMS  will receive
0.84338 of a share of the Company's common stock per share of Horizon/CMS common
stock. The transaction is valued at approximately $1,600,000,000,  including the
assumption by the Company of approximately  $700,000,000 in Horizon/CMS debt. It
is  expected  that  the  transaction  will  be  accounted  for  as  a  purchase.
Consummation  of the  transaction  is subject to various  regulatory  approvals,
including clearance under the Hart-Scott-Rodino  Antitrust Improvements Act, and
to  the  satisfaction  of  certain  other  conditions.   The  Company  currently
anticipates that the transaction will be consummated in mid-1997.

         The  Company  intends  to pursue  the  acquisition  or  development  of
additional   healthcare   operations,    including   comprehensive    outpatient
rehabilitation facilities,  ambulatory surgery centers, inpatient rehabilitation
facilities  and companies  engaged in the  provision of  outpatient  surgery and
rehabilitation-related   services,   and  to  expand  certain  of  its  existing
facilities.  While it is not possible to estimate  precisely  the amounts  which
will actually be expended in the foregoing areas,  the Company  anticipates that
over  the  next  twelve  months,  it will  spend  approximately  $50,000,000  on
maintenance  and  expansion  of  its  existing   facilities  and   approximately
$300,000,000 on development of the Integrated  Service Model,  pursuant to which
the Company  plans to utilize its services in  particular  markets to provide an
integrated continuum of coordinated care.

          Although  the  Company  is  continually   considering  and  evaluating
acquisitions and  opportunities  for future growth,  the Company has not entered
into any agreements with respect to material future  acquisitions other than the
transaction with Horizon/CMS. In connection with the pending acquisition of

                                    Page 13
<PAGE>



Horizon/CMS,  the  Company has  obtained a  fully-underwritten  commitment  from
NationsBank,   N.A.  for  a  $1,000,000,000   Senior  Bridge  Loan  Facility  on
substantially  the  same  terms  as the  1996  Credit  Agreement.  In  addition,
NationsBank, N.A. has provided the Company with a $300,000,000 interim revolving
credit facility for working capital purposes on substantially  the same terms as
the 1996  Credit  Agreement,  pending  the  closing  of the Senior  Bridge  Loan
Facility.  The Company  believes that existing cash, cash flow from  operations,
and  borrowings  under the  revolving  line of credit and the interim and bridge
loan  facilities  will be  sufficient to satisfy the  Company's  estimated  cash
requirements  for the next twelve  months,  and for the  reasonably  foreseeable
future.

         Inflation  in  recent  years  has not had a  significant  effect on the
Company's  business,  and is not expected to adversely affect the Company in the
future unless it increases significantly.

         Statements  contained in this  Quarterly  Report on Form 10-Q which are
not historical facts are forward-looking  statements.  In addition, the Company,
through its senior management,  from time to time makes  forward-looking  public
statements  concerning its expected future  operations and performance and other
developments.   Such  forward-looking   statements  are  necessarily   estimates
reflecting  the  Company's  best  judgment  based upon current  information  and
involve a number of risks and uncertainties,  and there can be no assurance that
other factors will not affect the accuracy of such  forward-looking  statements.
While it is impossible  to identify all such factors,  factors which could cause
actual results to differ materially from those estimated by the Company include,
but are not limited to, changes in the regulation of the healthcare  industry at
either or both of the federal and state levels, changes in reimbursement for the
Company's services by governmental or private payors,  competitive  pressures in
the  healthcare  industry and the  Company's  response  thereto,  the  Company's
ability to obtain and retain favorable  arrangements  with  third-party  payors,
unanticipated  delays in the Company's  implementation of its Integrated Service
Model,  general conditions in the economy and capital markets, and other factors
which  may be  identified  from  time to time in the  Company's  Securities  and
Exchange Commission filings and other public announcements.

                                    Page 14
<PAGE>



PART II -- OTHER INFORMATION

Item 2.           CHANGES IN SECURITIES.

(c)     Recent Sales of Unregistered Securities

                  There  were  no  sales  of  securities  in  transactions   not
                  registered  under  the  Securities  Act of 1933,  as  amended,
                  during the period  covered  by this  Quarterly  Report on Form
                  10-Q.


Item 4.           SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS .

                  The  information  required  under  this  item  was  previously
                  reported  under Item 4 of the Company's  Annual Report on Form
                  10-K for the  fiscal  year ended  December  31,  1996,  and is
                  hereby incorporated herein by reference.


Item 6.           EXHIBITS AND REPORTS ON FORM 8-K.

(a)      Exhibits

                  11.  Computation of Income Per Share (unaudited)
                  27.  Financial Data Schedule

(b)      Reports on Form 8-K

                  During the three  months  ended  March 31,  1997,  the Company
                  filed (i) a Current  Report  on Form 8-K  filed  February  19,
                  1997,  reporting  under  Item 5 the  proposed  acquisition  of
                  Horizon/CMS Healthcare Corporation,  and (ii) a Current Report
                  on Form 8-K filed March 13, 1997,  reporting  under Item 2 the
                  consummation  of the  acquisition of Health  Images,  Inc. and
                  incorporating   by   reference   under  Item  7  the  required
                  historical  financial  statements of Health  Images,  Inc. and
                  related pro forma financial information.



         No other  items of Part II are  applicable  to the  Registrant  for the
period covered by this Quarterly Report on Form 10-Q.

                                    Page 15
<PAGE>



                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly caused this Amendment No.1 to this Report to be signed
on its behalf by the undersigned thereunto duly authorized.


                                        HEALTHSOUTH CORPORATION
                                        -----------------------
                                            (Registrant)



Date: September 25, 1997                  RICHARD M. SCRUSHY
                                     ----------------------------
                                          Richard M. Scrushy
                                      Chairman of the Board and
                                       Chief Executive Officer





                                    Page 16






                                                                      EXHIBIT 11

                    HEALTHSOUTH CORPORATION AND SUBSIDIARIES

                   COMPUTATION OF INCOME PER SHARE (UNAUDITED)

                    (IN THOUSANDS, EXCEPT FOR PER SHARE DATA)

<TABLE>
<CAPTION>


                                                                                      THREE MONTHS ENDED
                                                                                            MARCH 31,
                                                                                 1997                   1996
                                                                          ------------------     ------------------

PRIMARY:
<S>                                                                          <C>                    <C>    
Weighted average common shares outstanding                                     327,727                315,443
Net effect of dilutive stock options                                            15,045                 20,708
                                                                              --------               --------

        Total Common and Common Equivalent Shares                              342,772                336,151
                                                                              ========               ========

Net income                                                                    $ 64,580               $ 39,681
                                                                              ========               ========

Net income per common and common equivalent share                             $   0.19               $   0.12
                                                                              ========               ========


FULLY DILUTED:
Weighted average common shares outstanding                                     327,727                315,443
Net effect of dilutive stock options                                            15,045                 20,708
                                                                              --------               --------
                                                                               342,772                336,151
Assumed conversion of 5% Convertible Subordinated
   Debentures due 2001                                                          12,226                 12,226
                                                                              --------               --------

        Total Common and Common Equivalent Shares,
        Fully Diluted                                                          354,998                348,377
                                                                              ========               ========

Net income                                                                    $ 64,580               $ 39,681

Elimination of interest and amortization on 5%
   Convertible Subordinated Debentures due 2001, less
   the related effect on the provision for income taxes                            960                    951
                                                                              --------               --------

Net income, fully diluted                                                     $ 65,540               $ 40,632
                                                                              ========               ========

Net income per common and common equivalent share                             $   0.18               $   0.12
                                                                              ========               ========
</TABLE>


                                    Page 17

<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                      1000
<CURRENCY>                                  US Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                         151,351
<SECURITIES>                                     3,842
<RECEIVABLES>                                  903,664
<ALLOWANCES>                                  (323,446)
<INVENTORY>                                     47,756
<CURRENT-ASSETS>                               940,872
<PP&E>                                       2,025,165
<DEPRECIATION>                                (490,777)
<TOTAL-ASSETS>                               3,705,839
<CURRENT-LIABILITIES>                          311,686
<BONDS>                                      1,624,311
                                0
                                          0
<COMMON>                                         3,274
<OTHER-SE>                                   1,643,793
<TOTAL-LIABILITY-AND-EQUITY>                 3,705,839
<SALES>                                              0
<TOTAL-REVENUES>                               691,631
<CGS>                                                0
<TOTAL-COSTS>                                  456,138
<OTHER-EXPENSES>                                57,371
<LOSS-PROVISION>                                14,713
<INTEREST-EXPENSE>                              25,673
<INCOME-PRETAX>                                122,899
<INCOME-TAX>                                    42,411
<INCOME-CONTINUING>                             64,580
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    64,580
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.18
        
                                    

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission